Brind.
  1. Evotec, Bristol Myers Squibb, and Sandoz announced the evolution of their strategic partnership and financial results from Hamburg.

Evotec successfully lists on Nasdaq and validates its model through a transaction with Sandoz, building on its partnership with Sandoz.

2 reports, 2 independent Updated Aug 17
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Evotec successfully lists on Nasdaq and validates its model through a transaction with Sandoz, building on its partnership with Sandoz.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped